WWB

WINDWARD BIO GROUP AG

Unclassified

Insider activity for last month from Oct 17 to Nov 17.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$00 sales
Net open-market$0Buying minus selling
Active insiders8Distinct reporting owners

WWB transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
InsiderActivityDisclosed valueFiled (ET)
Stampacchia Otello
Director
DIR
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Bonita David P
Director
DIR
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
D'Augusta Claudia
Chief Financial Officer
CFO
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Khwaja Omar
CMO
CMO. Role codes can represent multiple titles; the list does not include the filing title.
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Santarelli Luca
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Kapadia Sandip
Director
DIR
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Kapadia Sandip
Director
DIR
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
SEC filing ↗
$0View disclosure →
Harris Kevin Andrew
Chief Operating Officer
COO
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large disposal
Units disposed were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Harris Kevin Andrew
Chief Operating Officer
COO
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
SEC filing ↗
$0View disclosure →
Applebaum Scott
CL · CDO
CL, CDO. Role codes can represent multiple titles; the list does not include the filing title.
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Applebaum Scott
CL · CDO
CL, CDO. Role codes can represent multiple titles; the list does not include the filing title.
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
SEC filing ↗
$0View disclosure →

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Nov 16, 2026

Open-market transaction mix · 0 transactions in the selected period

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Oct 2026000$0$0$0
Nov 20260011$0$0$0

Distinct insiders active

Reporting-owner CIKs by month · peak Nov 2026 (8)
Oct 2026: 0 insidersNov 2026: 8 insiders
Oct 2026Nov 2026
8distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
5 insiders
Filing, role and holdings details

Filing-only signals

Deterministic matches in the selected period

Recent filing activity
Most recent 6 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy—
Largest sale—
10b5-1 detected0
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
11transactionstxns
  • A · Grants / awards · dominant11 · 100%

Activity by reported role

A joint filing can contribute to multiple roles
Director4
CDO2
CL2
COO2
Chief executive officer1
Chief financial officer1
CMO1

Reported Holdings After

Separated by insider, security, and ownership type

Applebaum ScottEmployee Share Option (Right to Buy) · Direct
180k180kNov 12, 2026Nov 12, 2026
180,160Nov 12, 2026
Harris Kevin AndrewEmployee Share Options (Right to Buy) · Direct
180k180kNov 12, 2026Nov 12, 2026
180,160Nov 12, 2026
Kapadia SandipShare Option (right to buy) · Direct
22.7k22.7kNov 12, 2026Nov 12, 2026
22,675Nov 12, 2026
Santarelli LucaEmployee Share Option (Right to Buy) · Direct
816k816kNov 12, 2026Nov 12, 2026
815,755Nov 12, 2026
Khwaja OmarEmployee Share Option (Right to Buy) · Direct
219k219kNov 12, 2026Nov 12, 2026
219,030Nov 12, 2026
D'Augusta ClaudiaEmployee Share Option (Right to Buy) · Direct
180k180kNov 12, 2026Nov 12, 2026
180,160Nov 12, 2026
Bonita David PStock Option (right to buy) · Direct
22.7k22.7kNov 12, 2026Nov 12, 2026
22,675Nov 12, 2026
Stampacchia OtelloShare Option (right to buy) · Direct
22.7k22.7kNov 12, 2026Nov 12, 2026
22,675Nov 12, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
1 active days
Oct 17 → Nov 17
LessMore

WINDWARD BIO GROUP AG Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at WINDWARD BIO GROUP AG?

Stampacchia Otello, Bonita David P, D'Augusta Claudia, Khwaja Omar, Santarelli Luca, Kapadia Sandip, Harris Kevin Andrew, Applebaum Scott.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

No code-S sale is available for this period.

What is the recent purchase and sale balance?

No code-P purchases or code-S sales were reported in the selected period.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.